The latest issue of Advances in Pulmonary Hypertension addresses Group 5 pulmonary hypertension (PH).
Group 5 PH is difficult to diagnose and challenging to manage because of the variability of underlying conditions and the ways PH presents, co-editor Anjali Vaidya, M.D., says.
“We hope that the readers will find this issue thought provoking, educational and practical,” co-editor Oksana Shlobin, M.D., says. “It is our hope that with the increased awareness of pulmonary hypertension in general, this often under-recognized and under-appreciated group will be on the forefront of research, as more guidance is needed to help clinicians caring for these complicated patients.”
Volume 20, Issue 2, includes articles on:
Metabolic Disorders of Pulmonary Hypertension.
The Story of Group 5 Pulmonary Hypertension (historic context of the classification system and how Group 5 transformed into its current classification).
The Myriad Presentations of Sickle Cell Disease-Related Pulmonary Hypertension.
PH Roundtable: Sarcoidosis and Pulmonary Hypertension.
PH Grand Rounds: An Interesting Case of Sarcoidosis-Associated Pulmonary Hypertension.
Advances in Pulmonary Hypertension is the Pulmonary Hypertension Association (PHA)’s quarterly peer-reviewed clinical journal. Advances is available for free online. Learn when the issue is available.